All providers
Sign in
Sign up to use European Medicines Agency
Firecrawl Alexandria
Health

European Medicines Agency

Try in Agent
Is natalizumab authorised in the EU, which products contain it and who holds the marketing authorisation?
1Request
string

category

string

next_cursor from a previous page with the same filters.

string

Exact EMA product number, e.g. EMEA/H/C/000603. No match is not_found.

5 credits
Codefollows the fields above
const result = await firecrawl.scrape({
  alexandria: {
    provider: "ema-europa-eu",
    capability: "records/medicines",
    options: {
      ema_product_number: "EMEA/H/C/000603",
    },
  },
});
2Response example

This is a sample shape. Press Run to see live data from European Medicines Agency.

{
  "attribution": "Source: European Medicines Agency (EMA), https://www.ema.europa.eu. Reproduced under EMA's legal notice, which requires EMA to be acknowledged as the source: https://www.ema.europa.eu/en/about-us/about-website/legal-notice",
  "data_timestamp": "2026-09-27T18:08:33Z",
  "dataset_records": 2746,
  "next_cursor": null,
  "observed_at_ms": 1790554594287,
  "records": [
    {
      "data": {
        "accelerated_assessment": "No",
        "active_substance": "natalizumab",
        "additional_monitoring": "No",
        "advanced_therapy": "No",
        "atc_code_human": "L04AG03",
        "atcvet_code_veterinary": "",
        "biosimilar": "No",
        "category": "Human",
        "conditional_approval": "No",
        "ema_product_number": "EMEA/H/C/000603",
        "european_commission_decision_date": "18/06/2026",
        "exceptional_circumstances": "No",
        "first_published_date": "02/08/2018",
        "generic": "No",
        "international_non_proprietary_name_common_name": "natalizumab",
        "last_updated_date": "06/07/2026",
        "latest_procedure_affecting_product_information": "VR/0000314828",
        "marketing_authorisation_date": "27/06/2006",
        "marketing_authorisation_developer_applicant_holder": "Biogen Netherlands B.V.",
        "medicine_status": "Authorised",
        "medicine_url": "https://www.ema.europa.eu/en/medicines/human/EPAR/tysabri",
        "name_of_medicine": "Tysabri",
        "opinion_adopted_date": "",
        "opinion_status": "",
        "orphan_medicine": "No",
        "patient_safety": "No",
        "pharmacotherapeutic_group_human": "Monoclonal antibodies",
        "pharmacotherapeutic_group_veterinary": "",
        "prime_priority_medicine": "No",
        "refusal_of_marketing_authorisation_date": "",
        "revision_number": "53",
        "species_veterinary": "",
        "start_of_evaluation_date": "",
        "start_of_rolling_review_date": "",
        "suspension_of_marketing_authorisation_date": "",
        "therapeutic_area_mesh": "Multiple Sclerosis",
        "withdrawal_expiry_revocation_lapse_of_marketing_authorisation_date": "",
        "withdrawal_of_application_date": ""
      },
      "ema_product_number": "EMEA/H/C/000603",
      "medicine_url": "https://www.ema.europa.eu/en/medicines/human/EPAR/tysabri",
      "name_of_medicine": "Tysabri"
    }
  ],
  "source_url": "https://www.ema.europa.eu/en/documents/report/medicines-output-medicines_json-report_en.json",
  "total_matching": 1,
  "withheld_fields": [
    "therapeutic_indication"
  ]
}

Related providers

Browse the library